Effectiveness of Interleukin-6 Receptor Inhibitors in the Management of Patients with Severe SARS-CoV-2 Pneumonia: An Open-Label, Multicenter Sequential and Cluster Randomized Trial

Primary Investigator & sponsor: Lars Erik Vølund Kristensen, MD, PhD, DMSci, Associate Professor (Lund & CPH Uni) The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen Co-Investigator: Hanne Rolighed Christensen, MD, PhD, Associate Professor Department of Clinical Pharmacology Bispebjerg and Frederiksberg Hospital Senior Biostatistician: Robin Christensen, BSc, MSc, PhD; Professor. The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen.